We found that higher baseline plasma MMP-9 correlated with worse baseline ADAS-cog scores among female but not male AD dementia patients, but higher baseline MMP-9 levels correlated with deteriorating ADAS-cog scores over time among male but not female AD dementia patients. The gene discussed is MMP9; the disease is Alzheimer disease.